The University of Nevada, Reno School of Medicine

CME Satellite Symposium Path to Relief Advancing Care in Atopic Dermatitis With JAK Inhibitors V5

Discuss strategies for effective clinical management of patients with atopic dermatitis (AD) inadequately controlled with biologic treatment 

Identify patients with moderate-to-severe AD for systemic therapy with Janus kinase (JAK) inhibitors 

Select the appropriate dose of JAK inhibitors to optimize treatment of AD